Tabula Rasa HealthCare Inc (NASDAQ:TRHC) President Orsula V. Knowlton sold 8,000 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $54.85, for a total transaction of $438,800.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of NASDAQ:TRHC opened at $54.78 on Monday. The business’s 50-day simple moving average is $49.52. The company has a quick ratio of 1.73, a current ratio of 1.80 and a debt-to-equity ratio of 1.31. Tabula Rasa HealthCare Inc has a one year low of $40.86 and a one year high of $91.16. The company has a market cap of $1.20 billion, a PE ratio of 161.12 and a beta of 1.62.
Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its quarterly earnings results on Wednesday, May 8th. The company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14). The firm had revenue of $60.96 million for the quarter, compared to analysts’ expectations of $59.24 million. Tabula Rasa HealthCare had a negative net margin of 18.15% and a positive return on equity of 4.22%. As a group, research analysts expect that Tabula Rasa HealthCare Inc will post -0.55 EPS for the current year.
Several institutional investors have recently added to or reduced their stakes in TRHC. First Mercantile Trust Co. increased its stake in shares of Tabula Rasa HealthCare by 64.5% during the 1st quarter. First Mercantile Trust Co. now owns 995 shares of the company’s stock worth $56,000 after purchasing an additional 390 shares during the last quarter. South Dakota Investment Council acquired a new position in shares of Tabula Rasa HealthCare during the 1st quarter worth about $141,000. Belpointe Asset Management LLC acquired a new position in shares of Tabula Rasa HealthCare during the 1st quarter worth about $172,000. LS Investment Advisors LLC increased its stake in shares of Tabula Rasa HealthCare by 11.2% during the 1st quarter. LS Investment Advisors LLC now owns 3,129 shares of the company’s stock worth $177,000 after purchasing an additional 316 shares during the last quarter. Finally, NumerixS Investment Technologies Inc acquired a new position in shares of Tabula Rasa HealthCare during the 1st quarter worth about $212,000. Institutional investors own 85.92% of the company’s stock.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.
Featured Story: Key terms to understand channel trading
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.